Anna Walz, Chief Executive Officer
From senior roles in advertising to the founding of MedEvoke, Anna has been a pioneer in the development of innovative business strategies, operational processes, products, and services. With Anna at the helm, MedEvoke has quickly become a leading partner to many top-20 pharmaceutical corporations. Her significant impact on the industry has also resulted in her appointment on the board of trustees of the Diversity Alliance for Science, Hunterdon Healthcare System, and as Chairman of the Board of Hunterdon Regional Community Health.
David Segarnick, Ph.D., Chief Medical Officer/Managing Partner
With degrees in pharmacology and neurochemistry and two decades in the industry, Dr. Segarnick has worked across most therapeutic areas and has supported the launches of blockbusters like Nexium, Prevnar 13, and Cervarix. Involved in every client initiative, he is an expert at building compelling narratives and bridging the communication gap between Commercial and Medical Affairs in client organizations.